News-Medical.NetPrefusion SARS-CoV-2 spike-based vaccine candidate shows high safety and efficacy in phase I trialApr 8, 2021Liji ThomasBy Liji Thomasbookmark_bordersharemore_vert
nejm.orgNeutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2 | NEJMJun 24, 2021bookmark_bordersharemore_vert
The ConversationWhat's the new coronavirus variant in India and how should it change their COVID response?Apr 6, 2021Giridhara R. Babu & Prafulla ShriyanBy Giridhara R. Babu & Prafulla Shriyanbookmark_bordersharemore_vert
STATScientists work toward an elusive dream: a simple pill to treat Covid-19Apr 9, 2021Damian GardeBy Damian Gardebookmark_bordersharemore_vert
The ConversationNew COVID variants have changed the game, and vaccines will not be enough. We need global 'maximum suppression'Apr 5, 2021Salim Abdool Karim, Jeffrey V. Lazarus & John LavisBy Salim Abdool Karim, Jeffrey V. Lazarus & John Lavisbookmark_bordersharemore_vert
The ConversationHow worried should you be about coronavirus variants? A virologist explains his concernsApr 8, 2021Paulo H. VerardiBy Paulo H. Verardibookmark_bordersharemore_vert